Super excited for tomorrow's ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!

They're FDA approved, have the best in class treatment, and is more affordable than the others.

$JAZZ $TGTX FDA APPROVED ON 12/28/22 . BUY/HOLD/ACCUMULATE

$KALA up 46%, rallies 3rd day in a row following FDA acceptance of IND application of KPI-012 & $TGTX is up 13% continued momentum following MS drug approvals.

Our best in class drug is FDA APPROVED.

$TGTX $KALA $HOTH $NUWE TGTX on fire 🔥 and solid from fundamentals perspective after yesterday FDA approval of Multiple Sclerosis Billion dollar drug revenue potential.

Great FDA approval news in a growing MS market with a need.

$TGTX , absolutely amazing….Scumbag’s Bank of America analyst rated TG today as underperform $6….total joke….I guess the analyst is waiting for FDA approval…LOL ….stick to loans and mortgages….very bullish TG community Longs….

$TGTX FDA approval for Billion dollar MS drug — great things in store 2023 $DRMA just officially dropped offering, makes me feel company has something good up it’s sleeve.

.. FDA APPROVED ON 12/28/22 BEST IN CLASS .

$PBLA a lot of times after the r/s companies announce some nice news $PALI for example and it’s news of expedited fda … glad to see it coming riding into the r/s sunset

Come april it will bounce nicely for 30% plus minus 5% IF fda approves.

$PALI FDA fast track $25 easy

$PALI you will not get cheaper than this 🔥 FDA already fast track the GI drug 🚨

FDA Fast Track Designation is gold.

$CDTX FDA decision will be made tomorrow $SAVA, $MDGL & $RETA boys I can easily see this up 200%-300% in my opinion on an approval.

$SAVA FDA approved Biogen's AD drug is bullish for SAVA.

no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!

$SAVA When FDA approved Aduhelm (aducanumab), which was a failure, on June 7 2021, SAVA was up 33% within a day following that news! !

My prediction: Phase 2 Unbelievable results FDA fast track Phase 3 - go ahead Patients receive sava Market cap 40 B by 2024 Rising to 200 Billion by 2026 Game changer - the only drug in the world to help patients

This formula has already proved to be effective, and if FDA approved can potentially be sold for billions.

FDA, do the right thing this time!

$SAVA the drug is 100% safe the fda has nothing to lose if they approve it for compassionate use.

Should be place on fast track by the FDA!